Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare | Drug Manufacturers - Specialty & Generic
₹1158.4
0.30% (₹3.5)
Market Overview
| Market Cap | 965876252672 |
| Volume | 1451873 |
| 52W High | ₹1421.49 |
| 52W Low | ₹1020.0 |
Key Ratios
| P/E Ratio | 18.00715 |
| EPS | 64.33 |
| Beta | 0.481 |
| Dividend Yield | 0.69% |
Financial Performance
Revenue Growth
0.159%
Profit Margin
0.17242001%
ROE
0.18474%
ROA
0.10318%
Stock Analysis Score: 75/100
Growth Score: 75/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Reasonable PE ratio between 15-25
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: 0.2% revenue growth indicates weak business expansion.
Profitability: 17.2% profit margin shows excellent operational efficiency.
Returns: ROE of 18.5% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 18.0x is reasonable compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹96587.6Cr
- Beta: 0.48 (Market Volatility)
- 52-Week Range: ₹1020.0 - ₹1421.5
Last Updated: 2025-04-16 19:36:58